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anism on the incidence and outcome of coronary dissection is unknown.
We analyzed 2293 lesions from the Heart Technology Multi-Center Registry
treated with RA to determine predictive factors for and outcomes following
coronary dissections. The incidence of dissection was 8%. Of the dissected
vessels, 22% showed evidence of persistent dye staining. There were no
differences in age (mean, 63yr) and gender (70% male) between the dissec-
tion and non-dissection groups. The incidence of hypertension, diabetes, hy-
percholesterolemia and smoking was not increased in patients with dissec-
tions. The frequency of prior MI, prior CABG and unstable symptoms was not
greater in patients with dissection. Patients with dissections were more likely
to have calcified lesions (57% vs 49%; p = 0.01), tortuous vessels (36% vs
23%; P < 0.001), AHA/ACC type C lesions (29% vs 18%; p = 0.0001) and
primary (79% vs 67%: p < 0.001) rather than restenotic lesions compared to
patients without dissection. Maximal burr size did not differ between the dis-
section and non-dissection groups. Following dissection, 15% of vessels had
sub-TIMIIII flow. Adjunctive PTCA increased the TIMIIiI flow rate to 94%. The
occurrence of dissection was associated with a greater residual stenosis fol-
lowing RA when compared to vessels without dissection (43% vs 38%) but
that difference was negated following adjunctive PTCA (23% vs 20%). Nev-
ertheless, the procedural success rate «50% residual stenosis without ma-
jor complications) was reduced in the presence of dissection (86% vs 96%;
p < 0.001) primarily because patients with dissection more frequently re-
quired CABG than those without dissection (6.4% vs 1.9%; P < 0.001). The
incidence of in-laboratory closure, out-of-Iaboratory closure, coronary pelio-
ration, Q-wave MI, non-Q MI and death were not increased in patients with
dissection.
ConclUSion: Coronary dissection is an uncommon complication of RA that
shares many predictors with PTCA but may have a more benign outcome.
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Thus, PB and Swere equally successful forthe treatment of acute or threat-
ened closure, with no significant difference in 3-month event-free survival.
S reclosure resulted in significantly higher mortality and costs due to longer
hospitalization, more repeat angiography and PTCA.
Ebo D. de Muinck, Peter den HeiJer, Hans-Otto Peels, Ad van Boven, Hans
L. Hillege. University Hospital, Groningen, The Netherlands
Treatment of acute or threatened closure during PTCA with a Stack perfusion
balloon (PB) or Palmaz-Schatz stent (S) was compared regarding: success
(stenosis < 50%, TI.M.1. 3 flow and no in-hospital reclosure or restenosis),
3-rnonth event-free survival, and cost of the intervention based on the total
duration of hospitalization, and the number of repeat interventions in hospi-
tal and during 3-month follow-up. During 3674 PTCA procedures 75 patients
were treated with a PB and 44 received a S for acute or threatened closure.
There were no statistically significant differences regarding: baseline clinical
characteristics, lesion morphology pre-PTCA and lesion morphology before
PB or S. Costs are: 500 US Dollars for 1 day in hospital. 400 for coronary an-
giography, 4790 for PTCA, 9160 for bypass surgery. Five patients died after S,
1 after PB (P < 0.05). In-hospital reclosure occurred 16 times in 12 patients
after S and in 1 patient after PB (P < 0.0002). The PB was successful in 54
(72%) patients and the S in 29 (66%) (P n.s.) There was no difference in 3-
month event-free survival.
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Stenting for Progressive Dissection During PTCA:
Clinical, Angiographic and Intravascular Ultrasound
Criteria to Define a Low-risk Group not ReqUiring
Subsequent Anticoagulation
Helmut Schuhlen, Rudolf Blaslni, Harald Mudra 1, Volker Klauss 1, Adnan Kastrati,
Eva Zitzmann, Petra Neller, Evelyn Regar, Ralph Paloncy, Albert Schomig.
Medizinische Klinik, Technische Universitat Miinchen Germany; 1 Medizinische Klimk
Innenstadt, Ludwig-Maximilians-UniversitBt MtJnchen, Germany
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Data from our previous experience with stenting suggest a subgroup of pa-
tients with a low risk for subacute occlusion of the stented vessel. Within
a six month study period, stents were implanted for progressive dissection
in 141 patients. These patients were screened for the following risk crite-
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Conclusion: Prior angioplastyof a target lesion (restenosis) is protective for
angiographic complications with new devices. Intralesional thrombus in the
setting of unstable angina or saphenous vein grafts confers an increased risk
of angiographic complications. These angiographic complications, in turn,
are predictive of major complications including nonfatal MI, emergency by-
pass surgery, and death.
Late Complications:
(out-ai-hospital death/
MI/CABG or repeat PTCA,
mean follow-up time =
8.8 ± 3.4 months)
S. Chiu Wong, Ya Chien Chuang, Richard A. Schatz, Donald S. Baim,
Sheldon Goldberg, Michael W. Cleman, Jeffrey A. Brinker, Steven R. Bailey, Martin
B. Leon. Washington Hospital Center. Washington, DC
Although well established biologic, anatomic, and angiographic predictors of
adverse clinical events are known for PTCA, there are a paucity of data af-
ter stent (S) implantation. Therefore we compared independent predictors
for adverse clinical events (procedural failure, restenosis, and late complica-
tions) after S (N = 205) vs PTCA (N = 202) treatment from the randomized
multicenter ~ent Restenosis ~tudy (STRESS) by performing multivariate lo-
gistic analysis.
were performed on 596 lesions in 561 patients including excimer laser angio-
plasty (n = 125), rotablator atherectomy (n = 111), and transluminal extrac-
tion atherectomy (n = 330) followed by adjunctive PTCA in 84% of lesions.
Final procedural success was achieved in 86%. Serious angiographic com-
plications (sidebranch occlusion, distal embolization, no reflow, abrupt clo-
sure, perforation) occurred in 9.4% of procedures after the new device and
persisting in 3.2% after adjunctive PTCA. Major complications (non-Q-wave
infarction, Q-wave infarction, emergency bypass surgery, death) occurred in
9.1 % of patients. Multiple logistic regression was performed on all clinical
and angiographic variables to identify independent predictors of serious an-
giographic and clinical complications:
In S pts, final minimal lumen diameter(MLD) strongly influenced procedure
failure, angiographic restenosis, and late complications. In PTCA pts, post-
PTCA dissection predicted procedural failure; diabetes, reference size, and
LAD predicted restenosis: there were no predictors of late complications.
In conclusion: The multivariate analysis of STRESS pt outcomes indicates
1) predictors for adverse clinical events were different for Sand PTCA, 2) S
neutralized the deleterious impact of biologic and anatomic factors on angio-
graphic restenosis and 3)final MLD after S placement, an operator-controlled
variable, strikingly predicted all adverse clinical outcomes. Therefore, metic-
ulous operator attention to optimize final MLD after S placement with appro-
priate adjunct PTCA may further improve clinical outcomes.
04:30
Predictors for Adverse Clinical Events are Different in
Stents and PTCA: Results from the STent REStenosis
Study
David L. Brown, Frank Giordano, Maurice Buchbinder. University of California, San
Diego Medical Center. San Diego, CA
Rotational atherectomy (RA) employs a novel methodology to debulk coro-
nary lesions. Ratherthan improving lumen dimension by stretching and split-
ting the artery as with balloon angioplasty (PTCA), RA differentially abrades
the less compliant atherosclerotic lesion. The effect of this unique mech-
1720-41 Coronary Dissection Following Rotational
Atherectomy: Clinical Characteristics, Angiographic
Predictors and Acute Outcomes
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ria which are based on our previous experience: stent in LAD, bail-out for
occlusion, major side branches within stented segment, adjacent stenoses
~50%, dissection not fully covered by stent, TIMII or II distal run-off, myocar-
dial infarction within the last two weeks, intracoronarythrombus, recanalized
chronic occlusions, minimal lumnial area within stent under 8 mm2 with in-
travascular ultrasound. 60 patients had less than two of these criteria, and
in a prospective trial were treated with heparin Lv. for 24 hours, and sub-
sequently received aspirin 200 mg/day and ticlopidin 500 mg/day (ambula-
tion after 36h). The final minimal lumen diameter achieved after stenting was
3.15 ± 0.55 mm (median 3.8% residual stenosis). Comparing the four-week
clinical follow-up of these patients with our previous experience in 301 pa-
tients all treated with coumadin, we saw no cardiac deaths (compared to
1.3%), no non-fatal myocardial infarction (3,9%), no subacute thrombotic
stent occlusions (6.9%), no need for repeat revascularization (PTCA orCABG)
of the stented vessel (7.3%); local vascular complications were seen in 1.7%
(30.2%), requiring surgery in none (5.6%), major bleeding not related to the
vascular access site occurred in 1.7% (9.0%). A six-month follow-up angiog-
raphy is scheduled.
Conclusions: Clinical, angiographic and ultrasound criteria allow the defini-
tion of a low-risk group of patients with stenting for progressive dissection.
Our data suggest that in these patients the risk for complications is substan-
tially decreased, and post-procedural anticoagulation is not required.
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1721-1 I Percutaneous Balloon Dilation as Initial Treatment for
Critical Aortic Stenosis. Results Up to 8.3 Years
Follow-up In 46 Consecutives Neonates
Eryberto S.T. Egilo, John F. Keane, Phillip Moore, John O'Sullivan, Sleven D. Colan,
Stanton B. Perry, James E. Lock. Children's Hospital, Boston, MA
The purpose of this study is to report our results with balloon dilation (BD) of
critical aortic stenosis (AS) in neonates. From 1985 to '91, 46 consecutive ba-
bies <33 days of age had BD for critical AS. The median age was 5 days, and
the mean weight was 3.2 kg; 41 (89%) was in congestive heart failure (CHF)
or shock, 33 (80%) intubated. Associated cardiac abnormalities were present
in 42 (91 %). The BD, performed retrograde in 43 (umbilical artery 23, femoral
artery 20), was completed in all, and with success in 41 (89%). The final bal-
loon to aortic annulus ratio was 0.91 ± 0.05. The overall mortality was 35%
(11 early and 5 late deaths 1.6 to 17 mos of follow-up). Of these 16, 4 were
considered related to BD, and 12 to associated left-sided lesions. All babies
who had BD via femoral artery had pulse loss, and anti-thrombotic therapy
restored pulses in 7 (35%). Significant aortic regurgitation (AR) post-BD was
observed in 5 (11 %) babies. An anatomic risk factor score for two-ventricle re-
pair(Rhodes et ai, 1991) was retrospectively measured, and 13 (38%) babies
had a score ~2 (critical AS with 2 or more associated left-sided obstructive le-
sions; high mortality). No neonate with an anatomic score ~2 survived longer
than 4 mos, except 1 who underwent successful Norwood operation. In uni-
variante analysis, an age of <3 days, a presentation in CHF or shock, and an
anatomic score ~2 were found to be related to mortality, but in a multivariante
analysis, only the anatomic score was significant (p = 0.001). Reintervention
was undertaken by 1 month in 22%, by 4 mos in 30%, and by 88 mos in 41 %;
the main indication was AS. At follow-up of 1.4 to 83 yrs (4.3 ± 1.8yrs), 30
(65%) were alive, and the clinical status was considered excellent or good in
90%. No child had leg length discrepancy. At Doppler study, a maximum gra-
dient >50 mmHg was found in 10 (33%), and significant AR was present in 4
(13%).
In conclusion, when no more than 1 associated left-sided obstructive le-
sion is present. BD for critical AS is effective; at 8.3 yrs of follow-up, the prob-
ability of being alive is 88%, and of being free from reintervention is 59%.
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1721-21 Aortic Valve Repair and Replacement After Balloon
Aortic Valvuloplasty In Children
John A. Hawkins, L. LuAnn Minich, Robert E. Shaddy, Lloyd Y. Tani, Jane
E. Sturtevant, Edwin C. McGough. Primary Children's Med Center and University of
Utah, Salt Lake City, UT
Little is known about the incidence, indications and results of surgical repair
or replacement of the aortic valve following balloon valvuloplasty for congeni-
tal aortic stenosis in children. This study was designed to evaluate patterns of
failure requiring surgery after balloon aortic valvuloplasty (BAli.) of congenital
AS and to review our experience with successful repair, rather than replace-
ment, of some aortic valves after BA\/. From 1986 to 1994, 54 patients with
congenital AS aged 1 day-27 years (mean ± sd; 8 ± 6 yrs) underwent BA\/.
Eighteen patients (33%) required surgery a mean of 33 ± 25 mos (range 1 to
80 mos) following BAli. because of severe AI in 10 patients and recurrent or
residual AS in 8 patients.
Severe AI was invariably due to avulsion of a cusp from the annulus with
resulting cusp prolapse and insufficiency. Actuarial freedom from surgical in-
tervention was 90 ± 4% at 1 year, 79 ± 6% at 3 years, and 64 ± 7% at 6 years.
The need for aortic valve surgery was unrelated to age at the time of BA\/.
Surgical intervention consisted of valve replacement in 11 patients and aor-
tic valve repair in 7 patients. Repair techniques included reattachment of an
avulsed cusp to the aortic annulus, relief of commissural fusion, and debride-
ment ofthickened cusps. All survived operation and are alive 23 ± mos (range
2-44 mos) following aortic valve operation. LV outflow gradient has been well
relieved in all patients undergoing valve replacement. The 7 valve repair pa-
tients have been followed 17 ± 10 mos (range 4-33 mos). Echocardiographic
follow-up of the valve repair patients revealed mild levels of residual AS and
mild (1-2+) AI in all patients.
Aortic valve surgery is required in 5-10% of patients yearly following BAli.
and appears to be unrelated to age at the time of BA\/. AI predominates over
AS as an indication for operative intervention. Valve repair can be applied in
some patients following BAli. with good intermediate-term results and may
delay the need for aortic valve replacement.
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1721-31 Five-to-Nine Year Follow-up Results of Balloon
Angioplasty of Native Aortic Coarctation
P. Syamasundar Rao, Omar Galal, Allen D. Wilson. Department of Pediatrics, Division
of Pediatric Cardiology, University of Wisconsin Medical School, University of Wisconsin
Children's Hospital, Madison, WI
Controversy exists with regard to the role of balloon angioplasty in the treat-
ment of native aortic coarctation. In an attempt to evaluate the usefulness of
this procedure we reviewed our experience with this procedure with a special
emphasis on follow-up results.
During an 8.7-year-period ending September 1993, 67 neonates, infants
and children underwent balloon angioplastywith resultant reduction in peak-
to-peak coarctation gradient from 48 ± 19(mean ± SD)to 11 ± 9 mmHg (P <
0.001). None required immediate surgical intervention. At intermediate-term
follow-up, catheterization (58 patients) and blood pressure (2 patients) data
revealed a residual gradient of 16 ± 15 mmHg. When individual results were
scrutinized 15 of 60 (25%) had recoarctation, defined as peak gradient >20
mmHg. Recoarctation was higher (P < 0.01) in neonates [5 of 6 (83%)] and
infants [7 of 18 (39%)] than in children [3 of 36 (8%)], respectively. Two infants
in our early experience had surgical resection with excellent results. Three pa-
tients had no discrete narrowing but had normal arm blood pressure and had
no intervention. The remaining 10 patients had repeat balloon angioplasty
with reduction of peak gradients from 52 ± 13 to 9 ± 8 mmHg (P < 0.001).
Reexamination 31 ± 18 months after repeat angioplasty revealed a residual
gradient of 3 to 19 (11 ± 6) mmHg. Three (5%) of 58 patients who under-
went follow-up angiography developed aneurysms. One child had a moder-
ate aneurysm and surgical resection was performed without difficulty. During
1 and 4 year follow-up, no further increase in the size of the aneurysm oc-
curred in the remaining two children.
Blood pressure, echo-Doppler and repeat angiographic or magnetic res-
onance imaging data 5 to 9 years after angioplasty revealed no new
aneurysms, normal blood pressures in 77% patients, and minimal (2%) late
recoarctation.
Based on these data it is concluded that balloon angioplasty is safe and ef-
fective in the treatment of native aortic coarctation; significant incidence of
recoarctation is seen in neonates and infants; repeat balloon angioplasty for
recoarctation is feasible and effective; 5 to 9 year follow-up is encouraging;
and the time has come to consider balloon angioplasty as a therapeutic pro-
cedure of choice for the treatment of native aortic coarctation.
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1721-41 Quantitative Echocardiographic Analysis of Aortic
Arch Morphometry Predicts Outcome of Balloon
Angioplasty of Native Coarctation of the Aorta
Stephen F. Kaine, E. O'8rian Smith, Charles E. Mullins, Tal Geva. Baylor College of
Medicine, Houston, Texas
To determine whether quantitative analysis of aortic arch morphometry can
predict outcome of balloon angioplasty(BA) of native coarctation of the aorta
(COA), we reviewed pre-angioplasty echocardiograms available on 105 pa-
tients undergoing BA from 1983-1994. Multiple aortic arch measures were
digitized off-line and indexed to BSA. Patients were categorized as angio-
plasty successes (residual systolic gradient <20 mmHg and freedom from in-
